MERIDIAN BIOSCIENCE, INC. (NASDAQ:VIVO) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02. Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
“Company“) announced it will commence a search for a new
Chief Executive Officer in connection with the planned retirement
of John A. Kraeutler in accordance with the terms of his
employment agreement. Mr. Kraeutler, the Company’s Chairman of
the Board of Directors, Chief Executive Officer and President,
plans to continue to serve in the capacity of CEO until his
successor is identified.
report and is incorporated herein by reference.
| 99.1 |
Press Release of the Company dated May 10, 2017
|
About MERIDIAN BIOSCIENCE, INC. (NASDAQ:VIVO)
Meridian Bioscience, Inc. is a life science company engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, viral, respiratory and parasitic infectious diseases, and elevated blood lead levels, and the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/quantitative PCR (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers. Its segments include Diagnostics and Life Science. The Diagnostics segment includes manufacturing operations in Cincinnati, and the sale and distribution of diagnostic test kits in the countries consisting of North, Central and South America; Europe, the Middle East and Africa (EMEA), and other countries outside of the Americas and EMEA. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; Luckenwalde, Germany, and Sydney, Australia. MERIDIAN BIOSCIENCE, INC. (NASDAQ:VIVO) Recent Trading Information
MERIDIAN BIOSCIENCE, INC. (NASDAQ:VIVO) closed its last trading session down -0.12 at 14.43 with 184,002 shares trading hands.